◆ 会议时间：2023年10月24日至27日
◆ 会议地点：美国 波士顿
◆ 会议简介：
2023年第16届阿尔茨海默病临床试验会议(CTAD)将于2023年10月24日至27日在美国波士顿举行，会议的目的是汇集当今全球阿尔茨海默病治疗领域的领导者，讨论对下一代阿尔茨海默病治疗发展至关重要宣的新结果、候选疗法和方法论问题。来自世界各地的临床试验团队将报告他们在识别新的疾病生物标志物以及更敏感的临床评估工具方面所做的努力，以识别AD风险人群、预测进展，并评估新疗法的有效性。未经许可禁止复制摘录转载本站任何内容国际医学会议网(lingyuint.com)。
CTAD 2023 - 16th Clinical Trials on Alzheimer's Disease Conference
Date: October 24-27, 2023
Location: Boston , Massachusetts, USA
CTAD 2023: What is coming next in Alzheimer’s Disease clinical research?
The 16th Clinical Trials on Alzheimer’s Disease conference (CTAD), will be held in Boston, Massachusetts (USA) on October 24-27, 2023.
This past November, in San Francisco, California, CTAD 2022 attracted over 2,800 international leaders to discuss the future of Alzheimer’s Disease clinical research with pivotal readouts from major pharmaceutical companies and new avenues of treatment beyond Amyloid and Tau.
The year 2022 has seen breakthrough advances with the market authorization of two anti-amyloid treatments, the emergence of diagnostic blood-based biomarkers and substantial results from Phase 1 to Phase 3 AD clinical trials.
At CTAD 2023, the scientific program will again focus on bringing thought-provoking roundtable and symposia on the latest advances in AD clinical research, bringing together renowned clinicians and leaders from key research centers, academia, patient coalition and pharmaceutical companies.
CTAD is also committed to exploring new avenues beyond amyloid-clearing treatments including disease-modifying agents, gene therapy, vaccines and multimodal interventions.
The CTAD scientific program is based on a strict peer-review abstract selection process. CTAD 2023 is a great opportunity for clinical teams around the world to showcase their work in AD clinical trials.
Proceedings from CTAD are published in the Journal of Prevention and Alzheimer’s Disease (Springer Nature Company)
摘要征文投稿：
The call for abstracts online submission system will open on March 1st, 2023
Deadline to submit June 1st at 11:59pm CET
Download the guidelines to submit a symposium
Download the guidelines to submit an oral communication or poster presentation
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
